Most powerful obesity drug yet: People lost up to 25% of weight in trial

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.

Ars Technica·September 29, 2026·1 min read

or via:

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.

This content is a summary of the original article published by Ars Technica. Visit the source for the full version.

Original Source

Ars Technica

Sponsored Listings